Prevalence of estimated GFR reporting among US clinical laboratories
about
Timing of Dialysis Initiation: What Has Changed Since IDEAL?Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.Characterizing pre-dialysis care in the era of eGFR reporting: a cohort studyThe association of eGFR reporting with the timing of dialysis initiationEthnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population.Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study.Development and results of a kidney disease knowledge survey given to patients with CKD.Estimation of GFR in South Asians: a study from the general population in Pakistan.Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.Screening tests for renal impairment in patients with type 2 diabetes: the what, when, and how.Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey.Special considerations in the management of chronic kidney disease in the elderlyPrevalence of chronic kidney disease in patients with spinal cord injuries/disorders.The Landscape of Diabetic Kidney Disease in the United States.Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
P2860
Q30234796-3E862739-1A46-44C6-B95C-BA2F5F4D13ABQ33793518-01A0A5B5-81A7-4577-B8B6-D2270824445EQ33846660-1C5E3019-A65D-45DC-9304-023F24D83EC9Q34103459-61A2978B-9E6D-4F7F-A8E2-E655F1876072Q34255617-7BE70DFC-6E4A-4EEE-9E2B-7A07522FD4D0Q34334349-0B29F5A5-F87E-4647-9A90-FF9F1C2E97FAQ34645471-E2420A67-C4E8-4C78-8861-EC9E6851F200Q35597386-7789F9AC-0EDC-4918-92B3-A730BD4DE8B4Q36157691-9A78C2FE-A9BD-4750-97CB-055BA58AC369Q37835610-C0D6CF7A-3753-43EE-891E-4C5A830641E2Q42627726-D47FF22F-CE75-4A0F-896E-234F46D4DC39Q42839516-6109D39B-286B-4C48-A6BF-93A457D71D62Q44524024-28DBE404-6114-40D4-94A0-9A8B74FC5B9EQ49862755-F5DC462F-5083-4A14-8F2D-1EC3732AB7E1Q51047130-D68A1DAF-4F0D-4B1C-BE2E-AE480A0CDCCE
P2860
Prevalence of estimated GFR reporting among US clinical laboratories
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prevalence of estimated GFR reporting among US clinical laboratories
@en
type
label
Prevalence of estimated GFR reporting among US clinical laboratories
@en
prefLabel
Prevalence of estimated GFR reporting among US clinical laboratories
@en
P2093
P2860
P1476
Prevalence of estimated GFR reporting among US clinical laboratories
@en
P2093
Andrew S Narva
Charles DiSogra
Elisa H Gladstone
Elizabeth C Wright
Michael Briggs
Nancy A Accetta
P2860
P304
P356
10.1053/J.AJKD.2008.05.023
P577
2008-08-03T00:00:00Z